Measures to lower drug prices were thrown off track by objections as senators battle over the issue, The Hill reported.
Senator John Cornyn was prepared to seek unanimous consent to pass a measure with Senator Richard Blumenthal, which is aimed at lowering drug prices by cracking down on drug companies playing the patent system to delay less expensive competition.
However, Cornyn eventually ran out of time, and "plans to renew the request next week," a Cornyn spokesman said.
Meanwhile, Speaker Nancy Pelosi is pushing a sweeping measure to allow the secretary of Health and Human Services to negotiate drug prices.
The pharmaceutical industry, which opposes both bills, had objected to an earlier version of Cornyn's bill.
The Pharmaceutical Research and Manufacturers of America said that it still opposes the bill, and that it "would fundamentally upend the biopharmaceutical innovation ecosystem."
To read more NewsPoints articles, click here.